Selected Grants
Cardiomyopathy associated with Friedreich¿s Ataxia
Clinical TrialPrincipal Investigator · Awarded by LEXEO Therapeutics, Inc · 2022 - 20294D MT - 4D-310_Follow Up - Taiwan
Clinical TrialPrincipal Investigator · Awarded by 4D Molecular Therapeutics · 2021 - 2028Gene Therapy 4D-310 in Adult Males with Fabry Disease
Clinical TrialPrincipal Investigator · Awarded by 4D Molecular Therapeutics · 2020 - 2028IMAGING FOR 1478-0002
Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim International GmbH · 2023 - 2027Lung Transplant Consortium - Data Coordinating Center
ResearchImaging Core PI · Awarded by National Institutes of Health · 2022 - 2027Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2027COR1167-201 study
Clinical TrialPrincipal Investigator · Awarded by Corteria Pharmaceuticals SAS · 2025 - 2026RECOVER-HF
ResearchPrincipal Investigator · Awarded by VisCardia, Inc. · 2024 - 2026SC21 WounDx Decision Support Tool
ResearchImaging Core PI · Awarded by Henry M. Jackson Foundation · 2023 - 2026Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2025Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization
Clinical TrialPrincipal Investigator · Awarded by HeartFlow, Inc. · 2019 - 2024CF-301 Phase III
Clinical TrialPrincipal Investigator · Awarded by ContraFect Corporation · 2019 - 2023CTEPH AI Project
ResearchPrincipal Investigator · Awarded by Bayer HealthCare, LLC · 2020 - 2021External Relationships
- American College of Cardiology
- American Heart Association
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.